Patents Assigned to INVENTIA HEALTHCARE PRIVATE LIMITED
-
Publication number: 20170027870Abstract: The present invention provides extended release pharmaceutical compositions structured for once a day administration comprising skeletal muscle relaxant such as cyclobenzaprine or its pharmaceutically acceptable salt thereof that extends the release of the drug under in-vitro conditions for at least 8 to 12 hours. The invention also provides process for the preparation of such structured compositions.Type: ApplicationFiled: October 13, 2016Publication date: February 2, 2017Applicant: INVENTIA HEALTHCARE PRIVATE LIMITEDInventors: SUNIL BEHARILAL JAISWAL, VAIBHAVI ANKUR SHAH, SUNIL DEVIPRASAD TIWARI
-
Patent number: 9498440Abstract: The present invention provides extended release pharmaceutical compositions structured for once a day administration comprising skeletal muscle relaxant such as cyclobenzaprine or its pharmaceutically acceptable salt thereof that extends the release of the drug under in-vitro conditions for at least 8 to 12 hours. The invention also provides process for the preparation of such structured compositions.Type: GrantFiled: May 20, 2010Date of Patent: November 22, 2016Assignee: INVENTIA HEALTHCARE PRIVATE LIMITEDInventors: Sunil Beharilal Jaiswal, Vaibhavi Ankur Shah, Sunil Deviprasad Tiwari
-
Publication number: 20160166510Abstract: The present invention provides stabilized prolonged release pharmaceutical compositions comprising atypical antipsychotic drug like paliperidone or pharmaceutically acceptable salts thereof without incorporating surfactant and for water penetration enhancer. Such compositions are preferably in the form of a matrix wherein one or more release controlling agents are present in and/or on the matrix. Further, such compositions comprise one or more release controlling agent and exhibits desired in vitro release of drug with or without lag period. The invention also provides a process for the preparation of such compositions.Type: ApplicationFiled: January 14, 2016Publication date: June 16, 2016Applicant: INVENTIA HEALTHCARE PRIVATE LIMITEDInventors: Sunil Deviprasad Tiwari, Vijayendrakumar Virendrakumarji Redasani, Prasad Shrikantrao Joshi, Vaibhav Narayan Sawarkar, Ankur Janak Shah
-
Patent number: 9271939Abstract: The present invention provides stabilized prolonged release pharmaceutical compositions comprising atypical antipsychotic drug like paliperidone or pharmaceutically acceptable salts thereof without incorporating surfactant and/or water penetration enhancer. Such compositions are preferably in the form of a matrix wherein one or more release controlling agents are present in and/or on the matrix. Further, such compositions comprise one or more release controlling agent and exhibits desired in vitro release of drug with or without lag period. The invention also provides a process for the preparation of such compositions.Type: GrantFiled: March 11, 2011Date of Patent: March 1, 2016Assignee: Inventia Healthcare Private LimitedInventors: Sunil Deviprasad Tiwari, Vijayendrakumar Virendrakumarji Redasani, Prasad Shrikantrao Joshi, Vaibhav Narayan Sawarkar, Ankur Janak Shah
-
Patent number: 8911781Abstract: A novel patient-convenient, cost effective pharmaceutical composition, comprising of thiazolidinediones and biguanide for controlling hyperglycemia manufactured as multilayer tablet and its process of manufacturing, for immediate release of thiazolidinediones or thiazolidinediones and biguanide and prolonged release of the biguanide only, the tablet comprising of minimum two layers wherein one outer layer comprises of a mixture of excipients and thiazolidinediones or thiazolidinediones and biguanide allowing immediate release of thiazolidinediones or thiazolidinediones and biguanide respectively and the other layer arranged in contact with the immediate release layer which comprises of a novel composition of excipients and a minimum one or more non-biodegradable, inert polymer(s) and the biguanide allowing pH independent prolonged release of the biguanide up to a period of 8-12 hours. The tablets are for once a day dosing.Type: GrantFiled: October 14, 2002Date of Patent: December 16, 2014Assignee: Inventia Healthcare Private LimitedInventors: Amit Krishna Antarkar, Rajendra Ghanshamlal Lala, Nirav Mahendra Kamdar, Parag Narayan Gadkari, Maya Janak Shah, Janak Ramanlal Shah
-
Patent number: 8871275Abstract: The present invention deals with extended release pharmaceutical compositions comprising tolterodine, wherein the composition comprises: a) a drug layer comprising tolterodine tartrate, monosaccharide and/or disaccharide on an inert core; or a drug core comprising tolterodine tartrate, monosaccharide and/or disaccharide; and b) a polymer layer comprising extended release polymer(s). The invention also provides a process for the preparation of the above mentioned composition.Type: GrantFiled: August 6, 2008Date of Patent: October 28, 2014Assignee: Inventia Healthcare Private LimitedInventors: Sunil Beharilal Jaiswal, Ankur Janak Shah
-
Publication number: 20130012524Abstract: The present invention provides stabilized prolonged release pharmaceutical compositions comprising atypical antipsychotic drug like paliperidone or pharmaceutically acceptable salts thereof without incorporating surfactant and/or water penetration enhancer. Such compositions are preferably in the form of a matrix wherein one or more release controlling agents are present in and/or on the matrix. Further, such compositions comprise one or more release controlling agent and exhibits desired in vitro release of drug with or without lag period. The invention also provides a process for the preparation of such compositions.Type: ApplicationFiled: March 11, 2011Publication date: January 10, 2013Applicant: Inventia Healthcare Private LimitedInventors: Sunil Deviprasad Tiwari, Vijayendrakumar Videndrakumarji Redasani, Prasad Shrikantrao Joshi, Vaibhav Narayan Sawarkar, Ankur Janak Shah
-
Publication number: 20120064164Abstract: The present invention provides extended release pharmaceutical compositions structured for once a day administration comprising skeletal muscle relaxant such as cyclobenzaprine or its pharmaceutically acceptable salt thereof that extends the release of the drug under in-vitro conditions for at least 8 to 12 hours. The invention also provides process for the preparation of such structured compositions.Type: ApplicationFiled: May 20, 2010Publication date: March 15, 2012Applicant: INVENTIA HEALTHCARE PRIVATE LIMITEDInventors: Sunil Beharilal Jaiswal, Vaibhavi Ankur Shah, Sunil Deviprasad Tiwari